Company intelligence / Profile preview

Fibroheal

Bangalore, Karnataka, Indiafibroheal.com ↗

Ownership: Private
Development stage: Commercial

Overview

Fibroheal has developed a range of advanced wound care products using silk proteins as biomaterials. Their offerings are well accepted in the Indian market with positive feedback from surgeons and patients. The company manufactures its own ISO13485/GMP-certified products and plans to expand internationally after obtaining CE certification. Clinical results are not detailed but user satisfaction and adoption by professionals are highlighted.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: BiologicDeviceProteinEnzyme
Industry: Biotech

Drug pipeline

2 assets

D-Fibroheal Scarlite

Commercial

Indications: C-section scars

1 more asset in the full pipeline.

Partnerships

Kitven FundGovernment of India’s Centre for Cellular and Molecular PlatformsTelama Investments

Beyond the preview

Go deeper on Fibroheal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibroheal.